Duodenal Ulcer
33
0
1
25
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.1%
2 terminated out of 33 trials
92.6%
+6.1% vs benchmark
45%
15 trials in Phase 3/4
28%
7 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (33)
A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer
To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.
Systems Biology of Gastrointestinal and Related Diseases
Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer
A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer
Helicobacter Pylori Eradication With a New Sequential Treatment
Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection
Nexium Capsules LDA Specific Clinical Experience Investigation
Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation
A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA
Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin
Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients
MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001)
Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation
A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy
A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy
BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects
Helicobacter Pylori Eradication Treatment in Patients With Duodenal Ulcers
Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer
Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer